首页> 美国卫生研究院文献>BMJ Case Reports >Unusual presentation of more common disease/injury: Do not miss rifampicin-induced thrombocytopenic purpura
【2h】

Unusual presentation of more common disease/injury: Do not miss rifampicin-induced thrombocytopenic purpura

机译:较常见的疾病/损伤的异常表现:不要错过利福平引起的血小板减少性紫癜

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug-induced immune thrombocytopenia (DITP) can be triggered by a wide range of medications. Although many cases of DITP are mild, some are characterised by life-threatening bleeding symptoms. In the treatment of tuberculosis there are special therapeutic problems related to adverse effects of drugs, compliance to treatment and microbial resistance. Thrombocytopenia is an uncommon but potentially fatal adverse effect of certain antituberculous drugs when the incriminating drug is taken by a susceptible individual. Here the authors report a case of rifampicin-induced thrombocytopenia, which although rare, needs attention.
机译:药物引起的免疫性血小板减少症(DITP)可以由多种药物触发。尽管许多DITP病例是轻度的,但有些特征是威胁生命的出血症状。在结核病的治疗中,存在与药物不良反应,对治疗的依从性和微生物抗性有关的特殊治疗问题。血小板减少症是某些抗结核药的罕见现象,但是当易感个体服用该病原性药物时,可能会致命。在这里,作者报告了一例利福平诱导的血小板减少症,尽管很少见,但需要引起注意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号